SAN DIEGO, May 1, 2012 /PRNewswire-iReach/ -- GenWay Biotech today announced the appointment of Mark Fitchmun as the company's new Vice President of GenWay Custom/OEM. This position was created as part of GenWay Biotech's efforts to focus on growth of the individual divisions including GenWay Custom/OEM, GenWay Catalog, and FirstMark Diagnostics. Since 1998, GenWay Biotech has provided the diagnostic and research communities with thousands specialty reagents and assays with unmatched quality workmanship at affordable prices. The company is recognized as a trusted out-sourcing partner throughout the world.
"GenWay leads the industry in product quality and customer satisfaction. We are truly proud of our reputation, and grateful for our customer's trust and support. Our customer's success, and contribution to our shareholders return on investment are the driving factors behind GenWay, and we are leveraging this success for our growth plans," stated Thomas Silberg, President and CEO of GenWay Biotech. "Mark's dedication to customer satisfaction, and his extensive experience in the biopharmaceutical industry developing and implementing robust manufacturing processes and assays, will be integral to GenWay Biotech's growth plans. We look forward to having him apply those same skills at GenWay."
As Vice President of GenWay Custom/OEM division, Fitchmun's primary role will be to lead the strategic direction for growth and day-to-day activities for the division. Fitchmun's 25 years of leadership and technical experience in the biopharmaceutical industry has ranged from small entrepreneurial biotech startups, to large established equipment and pharmaceutical companies. Since 1992, Fitchmun served as Principal for Somateck, Inc., where he provided development, manufacturing, and project management support to companies creating next generation biopharmaceuticals, diagnostics, research reagents, and kits for domestic and international clients. He has also held positions at biotech companies such a GenStar Therapeutics, Demos, Hygeia and Bio-Rad.
Fitchmun's unique qualifications will allow him to direct the expansion of the expertise, knowledge and technologies owned by GenWay, and to drive the development of cutting-edge enabling technologies to deliver faster, more reliable and cost-effective services and products than competitors. "GenWay is in an excellent position to grow the Custom/OEM division. Our talented team of scientists and technicians provide the utmost quality for custom reagent development, assay development and qualification for our clients in the pharmaceutical and diagnostics industry, " said Fitchmun. "I look forward to leading this impressive team, winning new contracts, and maintaining the highest level of service to enable the productivity of GenWay's clients."
About GenWay Biotech
FirstMark is a division of GenWay Biotech, Inc. The FirstMark division is focused on the development and commercialization of non-invasive diagnostic and health monitoring tests for unmet clinical needs. Headquarters are located in the heart of San Diego's biotech community in the Sorrento Valley/Mesa area. For additional information please visit GenWayBio.com.
About GenWay Biotech, Inc.
GenWay Biotech, is comprised of three divisions. GenWay's catalog products and custom services divisions are focused on protein and antibody solutions. The FirstMark division is focused on the development and commercialization of non-invasive diagnostic and health monitoring tests for unmet clinical needs. GenWay's headquarters are located in the heart of San Diego's biotech community in the Sorrento Valley/Mesa area. For additional information, please visit GenWayBio.com.
6777 Nancy Ridge Drive, San Diego, CA 92121 | P: 858.458.0866 | F: 858.458.0833
Media Contact: Deborah Moore GenWay Biotech, 858-458-0866, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
|SOURCE GenWay Biotech|
Copyright©2010 PR Newswire.
All rights reserved